Condition
Chronic Inflammatory Bowel Disease
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed2
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07305454RecruitingPrimary
Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic Inflammatory Bowel Diseases
NCT04692194Completed
Study "HEMORROIDAL SURGERY AND Chronic Inflammatory Bowel Disease"
NCT04698148Completed
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases
NCT04196920UnknownPrimary
Methotrexate-associated Anti-TNF Combination Therapy, the Neglected One !
Showing all 4 trials